Categories

Health care workers 👨🏾‍⚕️👩🏻‍⚕️ can improve the well-being of LGBTQ+ persons 🏳️‍🌈 🏳️‍⚧️, by providing high-quality care without discrimination. Support

Health care workers 👨🏾‍⚕️👩🏻‍⚕️ can improve the well-being of LGBTQ+ persons 🏳️‍🌈 🏳️‍⚧️, by providing high-quality care without discrimination.

Support the LGBTQ+ community’s 👩🏻‍🤝‍👩🏾👩🏾‍🤝‍👨🏻👨🏾‍🤝‍👨🏿 right to health and wellbeing.  

#HealthEquity https://t.co/9iQqBgUoC9

 
Categories

Ukoniq (umbralisib): Drug Safety Communication – FDA Approval of Lymphoma Medicine is Withdrawn Due to Safety Concerns

Due to safety concerns, the FDA has withdrawn its approval for the cancer medicine Ukoniq (umbralisib). Updated findings from the UNITY-CLL clinical trial continued to show a possible increased risk of death in patients receiving Ukoniq.

http://www.fda.gov/safety/medical-product-safety-information/ukoniq-umbralisib-drug-safety-communication-fda-approval-lymphoma-medicine-withdrawn-due-safety